ArticleThe Lancet regional health. Europe2026
Long-term adherence to glucose-lowering therapy and cardiovascular risk in type 2 diabetes: a nationwide cohort study.
Lise B Nielsen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.